<SEC-DOCUMENT>0000905148-25-002234.txt : 20250623
<SEC-HEADER>0000905148-25-002234.hdr.sgml : 20250623
<ACCEPTANCE-DATETIME>20250623184330
ACCESSION NUMBER:		0000905148-25-002234
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250618
FILED AS OF DATE:		20250623
DATE AS OF CHANGE:		20250623

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Hemrajani Rekha
		CENTRAL INDEX KEY:			0001771213
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40674
		FILM NUMBER:		251066257

	MAIL ADDRESS:	
		STREET 1:		3928 POINT EDEN WAY
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94545

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MAXCYTE, INC.
		CENTRAL INDEX KEY:			0001287098
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				522210438
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		9713 KEY WEST AVENUE,
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-517-5556

	MAIL ADDRESS:	
		STREET 1:		9713 KEY WEST AVENUE,
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MAXCYTE INC
		DATE OF NAME CHANGE:	20040415
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-06-18</periodOfReport>

    <issuer>
        <issuerCik>0001287098</issuerCik>
        <issuerName>MAXCYTE, INC.</issuerName>
        <issuerTradingSymbol>MXCT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001771213</rptOwnerCik>
            <rptOwnerName>Hemrajani Rekha</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O MAXCYTE, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>9713 KEY WEST AVENUE, SUITE 400</rptOwnerStreet2>
            <rptOwnerCity>ROCKVILLE</rptOwnerCity>
            <rptOwnerState>MD</rptOwnerState>
            <rptOwnerZipCode>20850</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2025-06-18</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>29210</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>50577</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.11</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2025-06-18</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>50790</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2035-06-17</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>50790</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>50790</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These shares represent restricted stock units (&quot;RSUs&quot;). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.</footnote>
        <footnote id="F2">This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date.</footnote>
    </footnotes>

    <remarks>Exhibit List: Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ David Sandoval, Attorney-in-Fact</signatureName>
        <signatureDate>2025-06-23</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>hemrajani_poa.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Sidley Austin LLP
         Document created using Broadridge PROfile 25.3.1.5296
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-weight: bold;">POWER OF ATTORNEY</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div> </div>
    <div style="text-indent: 36pt;">Know all by these present, that the undersigned hereby makes, constitutes and appoints each of Maher Masoud, David Sandoval and Douglas Swirsky, or either of them acting individually, and with full power of substitution,
      the undersigned's true and lawful attorney-in-fact to:</div>
    <div style="text-indent: 36pt;"> <br>
    </div>
    <div> </div>
    <table cellspacing="0" cellpadding="0" id="zfea7d49408b24f23814f2960fe718b16" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 31.5pt; vertical-align: top; color: #1F1F1F;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #1F1F1F;">prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents
              necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 13 or Section 16 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), Rule 144
              under the Securities Act of 1933 ("Rule 144"), or any rule or regulation of the SEC;</div>
            <div style="color: #1F1F1F;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <div> </div>
    <table cellspacing="0" cellpadding="0" id="zcd500a1087b04268ae551d9698f6b80e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 31.5pt; vertical-align: top; color: #1F1F1F;">(2)</td>
          <td style="width: auto; vertical-align: top;">
            <div><font style="color: #1F1F1F;">execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of </font>MaxCyte, Inc., <font style="color: #1F1F1F;">a Delaware corporation (the "Company"),</font><font style="font-family: 'Times New Roman', serif; font-size: 12pt;"> </font><font style="color: #1F1F1F;">any and all reports under Section 13 or Section 16 of the Exchange Act or any rule or regulation thereunder, or under Rule 144, with
                respect to the any security of the Company, including Forms 3, 4 and 5, Schedules 13D and 13G, and Form 144;</font></div>
            <div><font style="color: #1F1F1F;"> <br>
              </font></div>
          </td>
        </tr>

    </table>
    <div> </div>
    <table cellspacing="0" cellpadding="0" id="z19e9cec348cd4909907b81603822c8c6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 31.5pt; vertical-align: top;">(3)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #1F1F1F;">do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, Schedule 13D or 13G, or Form 144, complete and execute any
              amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and</div>
            <div style="color: #1F1F1F;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <div> </div>
    <table cellspacing="0" cellpadding="0" id="z44dcf435236b44b28c050f72e98edbe0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt;"><br>
          </td>
          <td style="width: 31.5pt; vertical-align: top;">(4)</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #1F1F1F;">take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned,
              it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in
              such attorney-in-fact's discretion.</div>
            <div style="color: #1F1F1F;"> <br>
            </div>
          </td>
        </tr>

    </table>
    <div> </div>
    <div style="text-indent: 36pt; color: #1F1F1F;">The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of
      any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such
      attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing
      attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 13(d) or Section 16 of the Exchange Act or Rule 144.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;"><font style="color: #1F1F1F;">This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file reports with the SEC with respect to the undersigned's holdings of and
        transactions in securities issued by the Company, unless earlier (a) revoked by the undersigned </font><font style="color: #3F3F3F;">i</font><font style="color: #1F1F1F;">n a signed writing delivered to the foregoing attorneys-in-fact or (b)
        superseded by a new power of attorney regarding the purposes outlined herein at a later date.</font></div>
    <div style="text-indent: 36pt;"><font style="color: #1F1F1F;"> <br>
      </font></div>
    <div style="text-indent: 36pt;">IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of 2/19/2025.<font style="color: #1F1F1F;"></font><br>
    </div>
    <br>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="ze6ecf7f9dd78417fb43b0c276ad04b42">

          <tr>
            <td style="width: 25%; padding-bottom: 2px;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%; padding-bottom: 2px;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman',Times,serif;">/s/ Rekha Hemrajani<br>
              </font></td>
            <td style="width: 25%; text-align: right; padding-bottom: 2px;" colspan="1"> <br>
            </td>
          </tr>
          <tr>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%; text-align: center;">Signature</td>
            <td style="width: 25%; text-align: right;" colspan="1"> <br>
            </td>
          </tr>
          <tr>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;" colspan="1"> <br>
            </td>
          </tr>
          <tr>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;" colspan="1"> <br>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; padding-bottom: 2px;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%; padding-bottom: 2px;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">Rekha Hemrajani<br>
              </div>
            </td>
            <td style="width: 25%; padding-bottom: 2px;" colspan="1"> <br>
            </td>
          </tr>
          <tr>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;">
              <div> </div>
              <br>
            </td>
            <td style="width: 25%;">
              <div style="text-align: center;"> Print Name</div>
            </td>
            <td style="width: 25%;" colspan="1"> <br>
            </td>
          </tr>

      </table>
    </div>
    <div style="color: rgb(31, 31, 31); font-family: 'Times New Roman',Times,serif;"><br>
      <font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 12pt;"> </font></div>
    <div style="color: rgb(31, 31, 31); font-family: 'Times New Roman',Times,serif;"><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><br>
      <font class="TRGRRTFtoHTMLTab" style="display: inline-block; font-size: 1px; width: 12pt;"> </font></div>
    <div style="color: rgb(31, 31, 31); font-family: 'Times New Roman',Times,serif;"><br>
    </div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
